Patients in the trial received Zeposia 0.92 mg (equivalent to 1 mg). SUNBEAM was a pivotal, Phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled trial evaluating the ...
Some results have been hidden because they may be inaccessible to you